FDA Updates Priority ANDA Pre-submission Guidance

Generic Line
A A
Responding to changes introduced by the GDUFA II program, the FDA revised its draft guidance on sponsor pre-submissions of facility information used to assess the need for manufacturing site inspections for priority applications.

To View This Article:

Login

Subscribe To Generic Line